Login / Signup

Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study.

Simone SchiavoConnor T A BrennaLisa AlbertiniGeorge DjaianiAnton MarinovRita Katznelson
Published in: PloS one (2024)
Patients with HF, including HFpEF, may develop HF symptoms during HBOT and warrant ongoing surveillance. However, these patients can receive HBOT safely after optimization of HF therapy and fluid restriction.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • public health
  • peritoneal dialysis
  • stem cells
  • mesenchymal stem cells
  • atrial fibrillation